Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-COV-2 (virus Responsible of COVID-19) Reinfection and Multisystem Inflammatory Syndrome in Children (MIS-C) Risk: Matched Case-control Study

NCT06255860 is registered in ClinicalTrials.gov with Association Clinique Thérapeutique Infantile du val de Marne as lead sponsor.

NCT NCT06255860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06255860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-COV-2 (virus Responsible of COVID-19) Reinfection and Multisystem Inflammatory Syndrome in Children (MIS-C) Risk: Matched Case-control Study
Lead sponsor
Association Clinique Thérapeutique Infantile du val de Marne
Phase
Observational
Overall status
Completed
Start date
September 22, 2023
Completion date
April 1, 2024
Enrollment
204 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mis-c, sars-cov-2 infection